March 2026
Xu S, Barry AR, Basiratmanesh S, Loewen PS, Pammett RT, Ragsdale P, Charrois TL, Wong YCJ, Dahri K. Patients’ perceptions of pharmacist prescribing for minor ailments and contraception in British Columbia, Canada. J Am Coll Clin Pharm 2026;9(1):e70168. doi: https://doi.org/10.1002/jac5.70168
Barry AR, Mattarollo E, Tsuyuki RT. Should all pharmacies have an automated external defibrillator? Can Pharm J (Ott) 2025;158(1 suppl):2S–5S. doi: https://doi.org/10.1177/17151635251382594
Mattarollo E, Tsuyuki RT, Barry AR. Pharmacies and automated external defibrillators: a literature review. Can Pharm J (Ott) 2025;158(1 suppl):6S–8S. doi: https://doi.org/10.1177/17151635251382587
Barry AR, Tsuyuki RT. The landscape of automated external defibrillators in pharmacies: a preliminary survey. Can Pharm J (Ott) 2025;158(1 suppl):9S–11S. doi: https://doi.org/10.1177/17151635251382588
Tsuyuki RT, Barry AR. Pharmacists’ experience with automated external defibrillators. Can Pharm J (Ott) 2025;158(1 suppl):12S–14S. doi: https://doi.org/10.1177/17151635251382591
Zed PJ, Abu-Laban RB. Emergency physicians and emergency pharmacists: a case study in the evolving “team sport” of emergency medicine. Can J Emerg Med 2026;28:85–6. https://doi.org/10.1007/s43678-026-01088-4
Yufan Hu, Wei Zhang, Daphne Guh, Aslam H. Anis. Impact of the U.S. 2025 tariff policy on Canadian pharmaceutical exports to the U.S.. Health Policy. Volume 167, 2026. https://doi.org/10.1016/j.healthpol.2026.105594
Cheng Vienna, Sayre Eric C., Amiri Neda, Cragg Jacquelyn J., Harrison Mark, Proulx Laurie, De Vera Mary A. (2026). Perinatal use of targeted synthetic DMARDs and maternal-neonatal outcomes in autoimmune disease: A population-based cohort study. Journal of Autoimmunity, 159, 103538. https://doi.org/10.1016/j.jaut.2026.103538
MacDonald BJ, Hawkins NM, Munday F, MacKay K, Turgeon RD. Non-Physician-Led Models of Care for Heart Failure Medication Optimization: A Scoping Review. Can J Cardiol Open 2026;[online 2026 Mar 9]. Available at: https://www.cjcopen.ca/article/S2589-790X(26)00089-2/fulltext
Turgeon R, Koshman S. Chapter: Heart Failure with Mildly Reduced or Preserved Ejection Fraction. In: Ambulatory Care Self-Assessment Program, 2026. ACSAP 2026. American College of Clinical Pharmacy; 2026.
Hosseini F, Labinaz A, Lee T, Brunham LR, Mancini J, Singer J, Turgeon R, Wong GC, Fordyce CB. Variability in Dyslipidemia Management following ST-elevation Myocardial Infarction: Insights from the LIPID-VAMOS Study. Eur J Prev Cardiol 2026[online 2026 Feb 19]:zwag117. Available at: https://doi.org/10.1093/eurjpc/zwag117
Turgeon RD, Moe SS, Garrison S. Tools for Practice #409 Less than 140, 130, or 120? Counting down to the optimal systolic blood pressure target. March 16, 2026. Available at: https://cfpclearn.ca/409/
Haddad K, Bainey K, Shavadia J, Potter BJ, Mansour S, Tanguay JF, Turgeon RD, Costa F, Lopes RD, Storey RF, Zeitouni M, Reid C, Marquis-Gravel G. Practice Patterns in Antiplatelet Management of Patients with Acute Coronary Syndromes Treated Medically Without Revascularization: a Multi-Center Survey. Can J Cardiol 2026;[online 2026 Mar 17]. Available at: https://onlinecjc.ca/article/S0828-282X(26)00267-9/fulltext
New paper from PhD candidate Amin Adibi and Dr. Mohsen Sadatsafavi: Surya P Bhatt, Amin Adibi, Sandeep Bodduluri, Russell P Bowler, Pierre-Régis Burgel, Peter J Castaldi, Craig P Hersh, Christer Janson, Enrico Maiorino, Hana Mullerova, Arie Nakhmani, Elizabeth C Oelsner, Edwin K Silverman, Carla G Wilson, Mohsen Sadatsafavi, Discriminative Performance and Clinical utility of COPD Exacerbation Categories for Predicting Future Exacerbations, American Journal of Respiratory and Critical Care Medicine, 2026;, aamag118, https://doi.org/10.1093/ajrccm/aamag118
Salil A, Nemir A, Kapanen AI, Zed PJ. Interprofessional team members’ experiences collaborating with a pharmacist in team-based primary care in British Columbia, Canada: a qualitative evaluation. Int J Clin Pharm, published on-line ahead of print, March 19, 2026. https://doi.org/10.1007/s11096-026-02121-3
Wang EHZ, Turgeon R, Chu E, Sun T, Bashir J, Peng D, Cook R, Atherstone J, Gwozd T, Ye J. Direct oral anticoagulants compared to warfarin early after cardiac surgery: a pilot randomized controlled trial. CJC Open 2026;[online 2026 Mar 27]:DOI: 10.1016/j.cjco.2026.03.011. Available at: https://www.cjcopen.ca/article/S2589-790X(26)00104-6/fulltext
Salimian S, Hawkins NM, Amegadzie JE, Sadatsafavi M, Turgeon RD. Performance of cardiovascular disease risk prediction tools in chronic obstructive pulmonary disease. Annals of the American Thoracic Society 2026;[online 2026 Mar 25];aaoag073. Available at: https://academic.oup.com/annalsats/advance-article/doi/10.1093/annalsats/aaoag073/8540475
McDonald EG, Gagnon, ME, Jorgenson DJ, Kraut RY, Lee J, Leung L, Mangin D, Marcoux G, McCracken RK, Raman-Wilms L, Sirois C, Trimble J, Young J, Rizvi A, Workentin A, Persaud N. Screening for potentially inappropriate prescribing in primary care: Canadian guideline. Canadian Family Physician, 2026;72(3), 173–178. https://doi.org/10.46747/cfp.7203173
Huerne K, Min J, Young E, Whitmore B, Leung L. Reconciliation through remote engagement: Evaluation of an online model for indigenous health education in pharmacy. Currents in Pharmacy Teaching and Learning. 2026;18(3): Article 102541. https://doi.org/10.1016/j.cptl.2025.102541
Gurman Khera, Karen Dahri, Louise Lau, Mimi Nguyen, Gian F. Soquena, Robert Pammett, Gigi Wong. British Columbia pharmacists’ perceptions on climate change and environmental sustainability. Canadian Pharmacists Journal / Revue des Pharmaciens du CanadaVol. 159, No. 2, pp134–145.https://doi.org/10.3138/cpj-25-0040
Turgeon RD, MacDonald BJ. ADVENTuring beyond conventional composite outcomes: The untapped potential of win statistics to embrace patient priorities. Can J Cardiol 2026;[online 2026 Mar 31];DOI: 10.1016/j.cjca.2026.03.044
Wang EHZ, Turgeon R, Chu E, Sun T, Bashir J, Peng D, Cook R, Atherstone J, Gwozd T, Ye J. Direct oral anticoagulants compared to warfarin early after cardiac surgery: a pilot randomized controlled trial. CJC Open 2026;[online 2026 Mar 27]:DOI: 10.1016/j.cjco.2026.03.011. Available at: https://www.cjcopen.ca/article/S2589-790X(26)00104-6/fulltext
Salimian S, Hawkins NM, Amegadzie JE, Sadatsafavi M, Turgeon RD. Performance of cardiovascular disease risk prediction tools in chronic obstructive pulmonary disease. Annals of the American Thoracic Society 2026;[online 2026 Mar 25];aaoag073. Available at: https://academic.oup.com/annalsats/advance-article/doi/10.1093/annalsats/aaoag073/8540475
